Buying a dividend stock at a cheap valuation can be a great move for several reasons. If a stock has declined in price but management has maintained its payout, new buyers can get a higher-than-usual yield from the investment.

This blue chip ASX stock has been sold off. Is it a buying opportunity for investors? Let's find out what Goldman Sachs is

Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) are both making outsized moves -- in opposite directions -- with the only common thread the ramped up option activity in response.

Investing in dividend stocks of blue-chip companies is a smart strategy for generating steady passive income and decent capital gains over time. These dividend-paying companies have large market caps,

Since 1926, dividends have accounted for nearly one-third of the S&P 500's total returns, highlighting their vital role in long-term investment performance. Despite higher government bond yields drawing some conservative investors away from equities,